{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Morgantown",
      "address_1": "781 Chestnut Ridge Rd",
      "reason_for_recall": "Failed Impurities/Degradation Specifications: High out of specification results obtained during routine stability testing",
      "address_2": "",
      "product_quantity": "8,159 bottles",
      "code_info": "Lot #: 3090167, Exp. October 2019",
      "center_classification_date": "20190215",
      "distribution_pattern": "Throughout the United States",
      "state": "WV",
      "product_description": "Diltiazem HCl Extended-Release Capsules, USP 180mg, Packaged in a) 100-count bottles (NDC 0378-5280-01), and b) 500-count bottles (NDC 0378-5280-05), Rx only, Manufactured by: Mylan Pharmaceuticals Inc. Morgantown, WV, 26505",
      "report_date": "20190227",
      "classification": "Class III",
      "openfda": {},
      "recalling_firm": "Mylan Pharmaceuticals Inc.",
      "recall_number": "D-0506-2019",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "82086",
      "termination_date": "20190912",
      "more_code_info": "",
      "recall_initiation_date": "20190213",
      "postal_code": "26505-2730",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}